Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease
Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease
Not yet recruiting · NCT06314698 · Registry updated 2024-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, bone disorder, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, musculoskeletal system disorder, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 3 | 2024-03-18 | NCT06314698 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| RenJi Hospital | 264 |
| Shanghai JMT-Bio Inc. | 30 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||